Get the Stockscreener App
6.19
4.56%
0.27
After Hours:
6.16
-0.03
-0.48%
Evolent Health Inc stock is traded at $6.19, with a volume of 2.20M.
It is up +4.56% in the last 24 hours and up +28.96% over the past month.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.
See More
Previous Close:
$5.92
Open:
$5.76
24h Volume:
2.20M
Relative Volume:
0.86
Market Cap:
$696.26M
Revenue:
$1.89B
Net Income/Loss:
$-496.52M
P/E Ratio:
-1.3005
EPS:
-4.7598
Net Cash Flow:
$1.40M
1W Performance:
+12.96%
1M Performance:
+28.96%
6M Performance:
+58.72%
1Y Performance:
-45.51%
1-Day Range:
$5.68
$6.255
1-Week Range:
$5.29
$6.255
52-Week Range:
$2.095
$11.81
Evolent Health Inc Stock (EVH) Company Profile
Name
Evolent Health Inc
Sector
Industry
Phone
571-389-6000
Address
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Compare EVH vs VEEV, BTSG, TEM, HQY, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
6.19 | 665.89M | 1.89B | -496.52M | 1.40M | -4.7598 |
VEEV
Veeva Systems Inc
|
193.09 | 31.97B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
69.67 | 13.67B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
58.67 | 10.04B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
94.50 | 8.00B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
89.31 | 6.96B | 646.34M | -512.40M | 202.76M | -6.6871 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-25-26 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Nov-13-25 | Initiated | BMO Capital Markets | Outperform |
| Nov-13-25 | Upgrade | Stephens | Equal-Weight → Overweight |
| Jan-10-25 | Initiated | Needham | Buy |
| Dec-03-24 | Reiterated | BTIG Research | Buy |
| Nov-08-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-09-24 | Upgrade | Truist | Hold → Buy |
| Apr-22-24 | Initiated | Citigroup | Buy |
| Mar-01-24 | Initiated | Oppenheimer | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-06-23 | Initiated | JMP Securities | Mkt Outperform |
| Oct-16-23 | Initiated | UBS | Buy |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Nov-01-22 | Initiated | Truist | Hold |
| Jul-29-22 | Initiated | RBC Capital Mkts | Outperform |
| Mar-30-22 | Initiated | Guggenheim | Buy |
| Nov-18-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-29-21 | Resumed | JP Morgan | Neutral |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Jul-06-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-05-20 | Downgrade | Goldman | Buy → Neutral |
| Jun-02-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Oct-05-18 | Resumed | Leerink Partners | Outperform |
| Jun-04-18 | Initiated | Piper Jaffray | Overweight |
| Apr-24-18 | Resumed | JP Morgan | Neutral |
| Sep-20-17 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jun-02-17 | Initiated | Robert W. Baird | Outperform |
| Mar-14-17 | Initiated | Oppenheimer | Outperform |
| Jan-13-17 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Oct-28-16 | Resumed | JP Morgan | Overweight |
| Aug-05-16 | Reiterated | FBR Capital | Outperform |
| Jul-26-16 | Initiated | Jefferies | Buy |
| Jul-13-16 | Reiterated | FBR Capital | Outperform |
| Mar-29-16 | Initiated | FBR Capital | Outperform |
| Jan-06-16 | Initiated | Canaccord Genuity | Buy |
| Jun-30-15 | Initiated | Goldman | Buy |
| Jun-30-15 | Initiated | JP Morgan | Overweight |
| Jun-30-15 | Initiated | Leerink Partners | Outperform |
| Jun-30-15 | Initiated | Sun Trust Rbsn Humphrey | Buy |
View All
Evolent Health Inc Stock (EVH) Latest News
EVH Stock On Track To Open At Record Low – Here’s Why Keybanc Turned Cautious - Stocktwits
Evolent To Release Second Quarter 2026 Financial Results on Thursday, August 6, 2026 - StreetInsider
Evolent set to report Q2 2026 results before Aug. 6 call - Stock Titan
Evolent Health (EVH) Piper Sandler 37th Annual Healthcare Conference Summary - Quartr
How Highmark Blue Shield is collaborating on value-based cancer care - The Business Journals
How Highmark Blue Cross Blue Shield is collaborating on value-based cancer care - The Business Journals
Avoiding Lag: Real-Time Signals in (EVH) Movement - Stock Traders Daily
EVHEvolent Health Inc Dividends - Finviz
Evolent Health (EVH) CEO gets 446,102 RSUs and has shares withheld for taxes - Stock Titan
Evolent Health | 4: Statement of changes in beneficial ownership of securities-Officer Weinberg Jonathan - Moomoo
Evolent Health (EVH) General Counsel receives RSU grant with tax-withholding entry - Stock Titan
Evolent Health (EVH) president receives 302,585 RSUs in equity grant - Stock Titan
Evolent Health (EVH) grants 28,790 RSUs to Chief Accounting Officer - Stock Titan
Evolent Health focuses on value-based care as investors watch long-term growth - Ad-hoc-news.de
Evolent Health Q1 2026 slides: revenue misses forecast, leverage rises - Investing.com
Should you buy Evolent Health (EVH) after golden cross? - MSN
Should You Buy Evolent Health (EVH) After Golden Cross? - Yahoo! Finance Canada
Truist Financial Downgrades Evolent Health(EVH.US) to Hold Rating, Maintains Target Price $7 - Moomoo
Truist Financial Maintains Evolent Health(EVH.US) With Hold Rating, Maintains Target Price $7 - Moomoo
Truist cuts Evolent Health stock rating on Medicaid headwinds By Investing.com - Investing.com South Africa
Truist cuts Evolent Health stock rating on Medicaid headwinds - Investing.com
Strength Seen in Evolent Health (EVH): Can Its 9.5% Jump Turn into More Strength? - Yahoo Finance
Enterprise value to EBIT forward of Evolent Health Inc Class A – FWB:9EH - TradingView
Price to sales forward of Evolent Health, Inc – NYSE:EVH - TradingView
Enterprise value to revenue forward of Evolent Health, Inc – NYSE:EVH - TradingView
Price to sales forward of Evolent Health Inc Class A – FWB:9EH - TradingView
Price to earnings forward of Evolent Health, Inc – NYSE:EVH - TradingView
Evolent Health Inc (EVH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Evolent Health quarterly loss narrows, shares react to value-based care focus - AD HOC NEWS
Discipline and Rules-Based Execution in EVH Response - Stock Traders Daily
Evolent Health Inc Class A Actuals & Estimates (NYSE:EVH) - TradingView
EVH Forecast — Price Target — Prediction for 2027 - TradingView
Citigroup Maintains Evolent Health (EVH) Buy Recommendation - MSN
Evolent Health Inc (EVH) Institutional Confidence - TradingKey
Evolent Health Inc Q1 2026 Earnings: Narrower Loss Delivers Strong EPS Surprise as Stock DeclinesGAAP Earnings Report - DonanımHaber
Evolent Health Inc (EVH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Evolent Health Inc (EVH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Evolent Health Inc (EVH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Evolent Health Inc (EVH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Evolent Health Inc (EVH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Evolent Health Inc (EVH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Evolent Health Inc (EVH) Valuation: PE, PB & Fair Value Analysis - TradingKey
Evolent Health Leads Healthcare Technology Sector Focus - Kalkine Media
Q1 2026 Earnings Season Results for Healthcare Technology for Providers StocksNews and Statistics - IndexBox
Q1 Earnings Outperformers: Evolent Health (NYSE:EVH) And The Rest Of The Healthcare Technology for Providers Stocks - Yahoo Finance
Truist Financial Maintains Evolent Health(EVH.US) With Buy Rating, Announces Target Price $7 - Moomoo
Evolent Health | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plansmoomoo - Moomoo
Director Toyin Ajayi granted 41,096 RSUs at Evolent Health (EVH) - Stock Titan
Evolent Health (EVH) director Russell Glass receives 41,096 restricted stock units - Stock Titan
Evolent Health (EVH) director receives 41,096 restricted stock units grant - Stock Titan
[Form 4] Evolent Health, Inc. Insider Trading Activity - Stock Titan
Evolent Health Inc Stock (EVH) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.56%
0.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):